Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer.
Besse B, Planchard D, Veillard AS, Taillade L, Khayat D, Ducourtieux M, Pignon JP, Lumbroso J, Lafontaine C, Mathiot C, Soria JC.
Besse B, et al.
Lung Cancer. 2012 Apr;76(1):78-83. doi: 10.1016/j.lungcan.2011.09.006. Epub 2011 Dec 18.
Lung Cancer. 2012.
PMID: 22186627
Clinical Trial.